Las instilaciones endovesicales en la terapia del cáncer superficial de la vejiga

Morante Deza, Carlos; Benavente Corrales, Víctor Angel; Pow Sang Godoy, Mariela; Meza Montoya, Luis.
Acta cancerol ; 29(1): 38-45, jul. 1999. tab, graf
Artículo en Español | LILACS, LIPECS | ID: lil-267227

Documentos relacionados

  1. [TEST FOR NEUTRALIZING ANTIBODIES IN UROLOGIC PATIENTS WITH NO RESPONSE TO INTRAVESICAL BOTULINUM TOXIN INJECTIONS].
  2. Re: Urine Cytology is a Feasible Tool for Assessing Erythematous Bladder Lesions after bacille Calmette-Guérin (BCG) Treatment.
  3. Clinical presentation of bacille Calmette-Guérin (BCG) infections after BCG instillation therapy.
  4. Progress and challenges in intravesical drug delivery.
  5. Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer.
  6. [Treatment for refractory non-neurogenic overactive bladder].
  7. Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study.
  8. Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials.
  9. Lacking transient receptor potential melastatin 2 attenuates lipopolysaccharide-induced bladder inflammation and its associated hypersensitivity in mice.
  10. Focus on the Use of Resveratrol in Bladder Cancer.